TherapeuticsMD Inc (TXMD) Stock Analysis

TherapeuticsMD Inc (TXMD) is a publicly traded company in the HEALTHCARE sector. It trades at $2.04, carries a market capitalization of $24.54M, a price-to-earnings ratio of 212.00. This page summarizes the public market data, fundamentals, and frequently asked questions for TXMD, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NASDAQ

Key Metrics

• Price: $2.04
• Market Cap: $24.54M
• P/E Ratio: 212.00
• EPS: $0.01
• 52-Week High: $2.95
• 52-Week Low: $0.98

Market Sentiment

TherapeuticsMD Inc currently has a Bullish sentiment score of 0.51.

About TherapeuticsMD Inc

TherapeuticsMD, Inc. is a pioneering women's healthcare company based in Boca Raton, Florida, committed to improving women's health through innovative prescription medications. The company specializes in addressing unmet medical needs in hormone therapy and contraception, underpinned by a strong pipeline and a robust research and development focus. With its strategic initiatives and dedication to advancing healthcare solutions, TherapeuticsMD is well-positioned to significantly enhance the qu...

GNG Research Analysis

GNG Research scores TherapeuticsMD Inc (TXMD) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for TXMD.

Frequently Asked Questions

Does TXMD pay dividends?

TherapeuticsMD Inc (TXMD) does not currently pay a regular dividend.

What is TXMD's P/E ratio?

TherapeuticsMD Inc has a price-to-earnings (P/E) ratio of 212.00.

What is TXMD's market cap?

TherapeuticsMD Inc (TXMD) has a market capitalization of $24.54M with a current stock price of $2.04.